• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿筛查与母婴诊断:重新思考家庭获益。

Newborn screening and maternal diagnosis: rethinking family benefit.

机构信息

University of North Carolina - Chapel Hill, Department of Social Medicine, 333 South Columbia Street, MacNider Hall, Room #348, Chapel Hill, NC 27599-7240, United States.

出版信息

Soc Sci Med. 2011 Oct;73(7):1014-8. doi: 10.1016/j.socscimed.2011.06.062. Epub 2011 Jul 27.

DOI:10.1016/j.socscimed.2011.06.062
PMID:21835525
Abstract

In a significant departure from established criteria for population screening, a 2006 report by the American College of Medical Geneticists (ACMG) argued that newborn screening may be justified by family and societal benefits even if the screened infant does not stand to benefit. The ACMG report has since been the backdrop for considerable debate about the presumptive benefits of newborn screening. Understandings of family benefits have focused on how information provided by newborn screening may enhance reproductive decision-making, reduce the diagnostic odyssey, and alleviate the burden of raising a child with special health care needs. This paper identifies and describes an additional consequence of newborn screening for families. Specifically, we draw upon audio-recordings and clinical observations from a three-year ethnographic study of expanded newborn screening in California (November 2007-July 2010) to examine the potential for newborn screening to diagnose mothers with genetic disorders. This consequence of expanded newborn screening suggests the possibility of a different type of family spillover from that anticipated by the ACMG report. However, whether this knowledge benefits families depends on how the significance of genetic information is established in the clinic and the family's ability to act on this information. We show that the newborn screening health care infrastructure is not designed to provide treatment for adult patients, so the identification of maternal disease does not necessarily prove beneficial for families.

摘要

与既定的人口筛查标准有重大背离的是,美国医学遗传学院(ACMG)在 2006 年的一份报告中指出,即使被筛查的婴儿本身无法受益,新生儿筛查也可能具有家庭和社会效益。自此,ACMG 的报告引发了关于新生儿筛查假定效益的大量争论。对家庭效益的理解侧重于新生儿筛查提供的信息如何能够增强生殖决策、减少诊断的曲折、减轻抚养有特殊医疗需求的孩子的负担。本文确定并描述了新生儿筛查对家庭的另一个后果。具体来说,我们借鉴了加利福尼亚州扩大新生儿筛查的三年民族志研究(2007 年 11 月至 2010 年 7 月)中的音频记录和临床观察,以研究新生儿筛查有可能诊断出患有遗传疾病的母亲。这种扩大的新生儿筛查的后果表明,可能存在与 ACMG 报告所预期的不同类型的家庭溢出。然而,这种遗传信息对家庭是否有益,取决于遗传信息在临床和家庭中的重要性如何确立,以及家庭能否据此采取行动。我们表明,新生儿筛查的医疗基础设施并非专为治疗成年患者而设计,因此,发现母亲患病并不一定对家庭有益。

相似文献

1
Newborn screening and maternal diagnosis: rethinking family benefit.新生儿筛查与母婴诊断:重新思考家庭获益。
Soc Sci Med. 2011 Oct;73(7):1014-8. doi: 10.1016/j.socscimed.2011.06.062. Epub 2011 Jul 27.
2
Impact of expanded newborn screening--United States, 2006.扩大新生儿筛查的影响——美国,2006年
MMWR Morb Mortal Wkly Rep. 2008 Sep 19;57(37):1012-5.
3
Changing perspectives on the benefits of newborn screening.对新生儿筛查益处的观点转变。
Ment Retard Dev Disabil Res Rev. 2006;12(4):270-9. doi: 10.1002/mrdd.20119.
4
Parental Opinions about the Expansion of the Neonatal Screening Programme.家长对新生儿筛查项目扩展的看法。
Community Genet. 2008;11(1):11-7. doi: 10.1159/000111635. Epub 2008 Jan 15.
5
An overview of newborn screening.新生儿筛查概述。
J Dev Behav Pediatr. 2010 Sep;31(7):622-31. doi: 10.1097/DBP.0b013e3181eedf01.
6
Integration of new genetic diseases into statewide newborn screening: New England experience.将新的遗传疾病纳入全州新生儿筛查:新英格兰地区的经验。
Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):35-41. doi: 10.1002/ajmg.c.30001.
7
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
8
Expanded newborn screening: articulating the ontology of diseases with bridging work in the clinic.扩展新生儿筛查:在临床中进行桥梁工作,阐明疾病的本体论。
Sociol Health Illn. 2012 Feb;34(2):208-20. doi: 10.1111/j.1467-9566.2011.01398.x. Epub 2011 Sep 19.
9
Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.串联质谱技术在遗传性代谢疾病新生儿扩大筛查中的应用:临床与实验室相关问题
Clin Biochem. 2006 Apr;39(4):315-32. doi: 10.1016/j.clinbiochem.2005.12.009. Epub 2006 Mar 23.
10
Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.关于扩大新生儿筛查的伦理、法律和社会问题:脆性X综合征作为新出现问题的一个范例
Pediatrics. 2008 Mar;121(3):e693-704. doi: 10.1542/peds.2007-0820.

引用本文的文献

1
Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases.为生命筛查:成人代谢专家对遗传性代谢疾病新生儿筛查的看法
J Inherit Metab Dis. 2025 Jul;48(4):e70057. doi: 10.1002/jimd.70057.
2
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.产前和新生儿筛查计划在健康经济评估中的获益和危害:VALENTIA 系统评价和定性研究。
Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591.
3
The social representations of diagnosing Lyme disease.
莱姆病诊断的社会表征。
PLoS One. 2023 Feb 9;18(2):e0276800. doi: 10.1371/journal.pone.0276800. eCollection 2023.
4
Exome/Genome-Wide Testing in Newborn Screening: A Proportionate Path Forward.新生儿筛查中的外显子组/基因组全范围检测:一条适度推进的道路。
Front Genet. 2022 Jul 4;13:865400. doi: 10.3389/fgene.2022.865400. eCollection 2022.
5
Absorbing it all: A meta-ethnography of parents' unfolding experiences of newborn screening.吸收一切:父母对新生儿筛查展开体验的元民族志研究。
Soc Sci Med. 2021 Oct;287:114367. doi: 10.1016/j.socscimed.2021.114367. Epub 2021 Sep 3.
6
What is in a Name? Parent, Professional and Policy-Maker Conceptions of Consent-Related Language in the Context of Newborn Screening.名字里有什么?新生儿筛查背景下父母、专业人士及政策制定者对同意相关用语的理解
Public Health Ethics. 2019 May 4;12(2):158-175. doi: 10.1093/phe/phz003. eCollection 2019 Jul.
7
Ethics in genetic counselling.遗传咨询中的伦理问题。
J Community Genet. 2019 Jan;10(1):3-33. doi: 10.1007/s12687-018-0371-7. Epub 2018 Jun 14.
8
Variation among Consent Forms for Clinical Whole Exome Sequencing.临床全外显子组测序知情同意书之间的差异。
J Genet Couns. 2018 Feb;27(1):104-114. doi: 10.1007/s10897-017-0127-2. Epub 2017 Jul 8.
9
International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.新生儿血斑筛查条件评估的国际差异:科学文献与政策文件综述
Eur J Hum Genet. 2016 Jan;25(1):10-16. doi: 10.1038/ejhg.2016.126. Epub 2016 Nov 16.
10
Newborn bloodspot screening policy framework for Australia.澳大利亚新生儿血斑筛查政策框架
Australas Med J. 2015 Sep 30;8(9):292-8. doi: 10.4066/AMJ.2015.2482. eCollection 2015.